The Latest in Obesity

Family Practice News

Obesity treatment in mental illness: Is semaglutide a game changer?

July 28, 2021

Family Practice News

Call to Action: Multidisciplinary panel urges coordinated care for ‘NASH epidemic’

July 26, 2021

Family Practice News

‘Wild West’ and weak evidence for weight-loss supplements

July 21, 2021

The Journal of Family Practice

Prescribe an SGLT2 inhibitor for heart failure in the absence of diabetes?

July 20, 2021

The Journal of Family Practice

Transitioning patients with developmental disabilities to adult care

July 20, 2021

Family Practice News

Admissions for eating disorders double in pandemic

July 15, 2021

Family Practice News

ADA/EASD draft guidance aims to bring adults with type 1 diabetes out of shadows

July 14, 2021

Family Practice News

New agents for youth-onset type 2 diabetes ‘finally in sight’

July 13, 2021

Family Practice News

Can overweight docs really give credible weight loss advice?

July 12, 2021

Family Practice News

Meta-analysis supports cardiovascular benefits of EPA

July 12, 2021

The Journal of Family Practice

Healthy weight gain in pregnancy: What the USPSTF recommends

July 9, 2021

Family Practice News

AGA Clinical Practice Update: Early complications after bariatric/metabolic surgery

July 9, 2021

Family Practice News

Semaglutide 2.4 mg ‘likely to usher in a new era’ in obesity treatment

June 29, 2021

Family Practice News

SUSTAIN FORTE: Higher-dose semaglutide safely boosts glycemic control, weight loss

June 27, 2021

Family Practice News

‘Staggering’ doubling of type 2 diabetes in children during pandemic

June 26, 2021